Leukaemia

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase I (First in Human): 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I (First in Human)

1 trial
  • ActiTrexx GmbH Commercial
    ALLOGENEIC CD4+ AND CD25+ T LYMPHOCYTES EX VIVO INCUBATED WITH GP120
    2024-516599-14-00 1 country 2023 n=10 Orphan
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
ActiTrexx GmbH Commercial 1 Phase I (First in Human) 0
New trials by year
2023
1
← All indication landscapes